These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Development of an enzyme-linked immunosorbent assay for the detection of human calretinin in plasma and serum of mesothelioma patients. Raiko I; Sander I; Weber DG; Raulf-Heimsoth M; Gillissen A; Kollmeier J; Scherpereel A; Brüning T; Johnen G BMC Cancer; 2010 May; 10():242. PubMed ID: 20509881 [TBL] [Abstract][Full Text] [Related]
7. Calretinin-expressing lung adenocarcinoma: Distinct characteristics of advanced stages, smoker-type features, and rare expression of other mesothelial markers are useful to differentiate epithelioid mesothelioma. Matsuda M; Ninomiya H; Wakejima R; Inamura K; Okumura S; Mun M; Kitagawa M; Ishikawa Y Pathol Res Pract; 2020 Mar; 216(3):152817. PubMed ID: 32008868 [TBL] [Abstract][Full Text] [Related]
8. Circulating activin A is a novel prognostic biomarker in malignant pleural mesothelioma - A multi-institutional study. Hoda MA; Dong Y; Rozsas A; Klikovits T; Laszlo V; Ghanim B; Stockhammer P; Ozsvar J; Jakopovic M; Samarzija M; Brcic L; Bendek M; Szirtes I; Reid G; Kirschner MB; Kao SC; Opitz I; Weder W; Frauenfelder T; Nguyen-Kim TD; Aigner C; Klepetko W; van Zandwijk N; Berger W; Dome B; Grusch M; Hegedus B Eur J Cancer; 2016 Aug; 63():64-73. PubMed ID: 27288871 [TBL] [Abstract][Full Text] [Related]
9. Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma. Thapa B; Walkiewicz M; Murone C; Asadi K; Deb S; Barnett S; Knight S; Mitchell P; Liew D; Watkins DN; John T Pathology; 2016 Dec; 48(7):660-665. PubMed ID: 27780599 [TBL] [Abstract][Full Text] [Related]
10. The established and future biomarkers of malignant pleural mesothelioma. Panou V; Vyberg M; Weinreich UM; Meristoudis C; Falkmer UG; Røe OD Cancer Treat Rev; 2015 Jun; 41(6):486-95. PubMed ID: 25979846 [TBL] [Abstract][Full Text] [Related]
11. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects. Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567 [TBL] [Abstract][Full Text] [Related]
12. c-Met expression and MET amplification in malignant pleural mesothelioma. Bois MC; Mansfield AS; Sukov WR; Jenkins SM; Moser JC; Sattler CA; Smith CY; Molina JR; Peikert T; Roden AC Ann Diagn Pathol; 2016 Aug; 23():1-7. PubMed ID: 27402216 [TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid in the pleural fluid of patients with malignant pleural mesothelioma. Fujimoto N; Gemba K; Asano M; Fuchimoto Y; Wada S; Ono K; Ozaki S; Kishimoto T Respir Investig; 2013 Jun; 51(2):92-7. PubMed ID: 23790737 [TBL] [Abstract][Full Text] [Related]
16. Detection of TGF-β in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma. Stockhammer P; Ploenes T; Theegarten D; Schuler M; Maier S; Aigner C; Hegedus B Lung Cancer; 2020 Jan; 139():124-132. PubMed ID: 31778960 [TBL] [Abstract][Full Text] [Related]
17. [Clinical and pathological profile of the pleural malignant mesothelioma: A retrospective study about 30 cases]. Mlika M; Lamzirbi O; Limam M; Mejri N; Ben Saad S; Chaouch N; Ben Miled K; Marghli A; Mezni F Rev Pneumol Clin; 2018 Dec; 74(6):427-435. PubMed ID: 30293912 [TBL] [Abstract][Full Text] [Related]
18. Fibulin-3 as a blood and effusion biomarker for pleural mesothelioma. Pass HI; Levin SM; Harbut MR; Melamed J; Chiriboga L; Donington J; Huflejt M; Carbone M; Chia D; Goodglick L; Goodman GE; Thornquist MD; Liu G; de Perrot M; Tsao MS; Goparaju C N Engl J Med; 2012 Oct; 367(15):1417-27. PubMed ID: 23050525 [TBL] [Abstract][Full Text] [Related]
19. Accuracy of pleural biopsy for the diagnosis of histologic subtype of malignant pleural mesothelioma: Necropsy-based study of 134 cases. Barbieri PG; Consonni D; Schneider M Tumori; 2022 Feb; 108(1):26-32. PubMed ID: 33719756 [TBL] [Abstract][Full Text] [Related]
20. Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort. Brosseau S; Danel C; Scherpereel A; Mazières J; Lantuejoul S; Margery J; Greillier L; Audigier-Valette C; Gounant V; Antoine M; Moro-Sibilot D; Rouquette I; Molinier O; Corre R; Monnet I; Langlais A; Morin F; Bergot E; Zalcman G; Levallet G Clin Lung Cancer; 2019 Sep; 20(5):e564-e575. PubMed ID: 31279641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]